The two derivatives in marijuana considered therapeutic are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD’s). The cleanest method to prepare a derivative from marijuana is super critical C02 extraction.
As a result of the recent Supreme Court of Canada decision, individuals authorized to possess marijuana under the MMPR may now possess marijuana derivatives for their own use. Based on this decision, Health Canada has issued a section 56 class exemption under the Controlled Drugs and Substances Act (CDSA), allowing licensed producers to produce and sell cannabis oil (under the MMPR). The licensed producer must hold a supplemental licence issued by the Minister of Health for the purpose of authorizing the activities in relation cannabis oil.
The two derivatives in marijuana considered therapeutic are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD’s). The cleanest method to prepare a derivative from marijuana is super critical C02 extraction. Other methods to extract isolated THC and CBD include the use of organic solvents (toxic and flammable). You can further purify or concentrate the oil using chromatography.
There are new rules for preparing and labelling the derivatives that must be taken into consideration prior to obtaining the right to produce the derivatives (oils). There is a maximum allowable concentration, specific label requirements, and formulation implications concerning the amount of active per dosage unit and the use of non-medicinal ingredients. There is also a requirement for enhanced documentation, including details of the extraction process.
NHP Consulting can provide you with consultation in developing extraction procedures and equipment, and also make an application on your behalf for a supplemental licence.